Vigene Biosciences goes big on Maryland viral vector expansion as it rides high on Altimmune vaccine deal
Boosted by a gangbusters year for Rockville-based Emergent BioSolutions and its viral vectors for Covid-19 vaccines, the state of Maryland has continued to cement its place as a hotbed for next-gen manufacturing. Now, a smaller player is looking to build out its own small foothold in the state.
Vigene Biosciences, also based in Rockville, has snagged a public-private partnership with the state of Maryland and its home base of Montgomery County to add 52,000 feet of manufacturing space at its headquarters site.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.